CRISPRi interrogation of the <i>Sox10</i> ECs. by Hongjoo An (21703199)

Quantitative immunofluorescence of Sox10 in mouse OLs after CRISPRi knockdown of EC1 and EC2. by Hongjoo An (21703199)

Effect of Sox10-E1 and Sox10-E2 on the expression of <i>Pick1.</i> by Hongjoo An (21703199)

The raw data for Fig 4. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for S2 Fig. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for Fig 6. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for S4 Fig. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for Fig 5B. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

Johnsen testicular biopsy score. by Halime Tozak Yıldız (21238185)

“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”

Nanoparticle tracking analysis. by Halime Tozak Yıldız (21238185)

“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”

Sperm count and motility. by Halime Tozak Yıldız (21238185)

“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”

Effects of compound 4f on cognitive function in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

Effects of compound 4f on the seizure-like response elicited by kainic acid (KA). by Naoto Arimura (416442)

Original data2. by Lan Zeng (638254)

“…<div><p>Diabetic retinopathy (DR) is a leading cause of blindness. …”

Original data1. by Lan Zeng (638254)

“…<div><p>Diabetic retinopathy (DR) is a leading cause of blindness. …”

Effects of compound 4f on neuronal cell loss in mice with KA-induced neurodegeneration. by Naoto Arimura (416442)

One-way sensitivity analysis. by Yiping An (20609789)

Cell type specificity of Sox10-E1 and Sox10-E2. by Hongjoo An (21703199)

Effective reproduction numbers of influenza in the United States from week 40 to week 17 in 2016–2017, 2017–2018, 2018–2019, 2022–2023, and 2023–2024. by Shuanglin Jing (11886368)

Estimation of influenza transmission and death rates among individuals aged 0–17, 18–64, and 65+ in the United States using actual data. by Shuanglin Jing (11886368)